[Cardiac sarcoidosis: Diagnosis, prognosis and therapeutics].
Sarcoïdose cardiaque : stratégies diagnostiques et thérapeutiques actuelles.
Anti-TNFα
Immunosuppressants
Immunosuppresseurs
Prognosis
Pronostic
Sarcoidosis
Sarcoïdose cardiaque
TNFα inhibitors
Traitement
Treatment
Journal
La Revue de medecine interne
ISSN: 1768-3122
Titre abrégé: Rev Med Interne
Pays: France
ID NLM: 8101383
Informations de publication
Date de publication:
Apr 2022
Apr 2022
Historique:
received:
11
06
2021
revised:
22
07
2021
accepted:
01
08
2021
pubmed:
23
3
2022
medline:
6
5
2022
entrez:
22
3
2022
Statut:
ppublish
Résumé
Sarcoidosis is a systemic granulomatous disease characterized by pulmonary involvement in most patients and more rarely by extrapulmonary involvement such as ocular, skin, salivary, lymph nodes and joints damages. Neurological and cardiac involvements are uncommon but are associated with increased morbidity and mortality. Cardiac sarcoidosis affects 5 to 20% of patients depending on the studies and autopsy studies even report cardiac involvement in 25% of sarcoidosis patients. This review aims to summarise main data on the diagnostic value of the different imaging techniques in cardiac sarcoidosis and to also detail the management of these patients who require a multidisciplinary approach.
Identifiants
pubmed: 35315339
pii: S0248-8663(21)00650-0
doi: 10.1016/j.revmed.2021.08.018
pii:
doi:
Types de publication
Journal Article
Review
Langues
fre
Sous-ensembles de citation
IM
Pagination
212-224Informations de copyright
Copyright © 2021. Published by Elsevier Masson SAS.